Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo-Reference-Cited by-同舟云学术

Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo

Published:2009-07-26 Issue:9 Volume:10 Page:1000-1007
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Zhou Xuyu,Bailey-Bucktrout Samantha L,Jeker Lukas T,Penaranda Cristina,Martínez-Llordella Marc,Ashby Meredith,Nakayama Maki,Rosenthal Wendy,Bluestone Jeffrey A

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni.1774.pdf

Reference39 articles.

1. Tang, Q. et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28, 687–697 (2008).

2. Bluestone, J.A., Tang, Q. & Sedwick, C.E. T regulatory cells in autoimmune diabetes: past challenges, future prospects. J. Clin. Immunol. 28, 677–684 (2008).

3. Wan, Y.Y. & Flavell, R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766–770 (2007).

4. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).

5. Bennett, C.L. & Ochs, H.D. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr. Opin. Pediatr. 13, 533–538 (2001).

Cited by 1085 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential therapeutic role of IL-35 in pathophysiological processes in type 1 diabetes mellitus;Cytokine;2024-10

2. Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence;International Immunopharmacology;2024-10

3. Effector memory–type regulatory T cells display phenotypic and functional instability;Science Advances;2024-09-06

4. mRNA-delivery of IDO1 suppresses T cell-mediated autoimmunity;Cell Reports Medicine;2024-09

5. Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation;Cell Reports;2024-09